We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZKH:NYSEZKH Group Limited Analysis

Data as of 2026-06-22 - not real-time

$2.53

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

ZKH is trading at $2.53, comfortably below its 20‑day (2.80), 50‑day (2.94) and 200‑day (3.13) simple moving averages, signaling a short‑term bearish price bias. The 14‑day RSI sits at 29.5, placing the stock in oversold territory and suggesting a potential rebound. Momentum indicators remain negative, with the MACD line under the signal line and a modest bearish histogram. Volatility is elevated at roughly 49% over the past month, while a low beta of 0.30 indicates limited correlation with broader market moves. On the balance sheet, the debt‑to‑equity ratio is strikingly high at 13.9, reflecting substantial leverage relative to equity. Nevertheless, valuation metrics appear attractive: a forward P/E of 11.5, a price‑to‑book of 0.95 and a price‑to‑sales of just 0.04.
Recent Q1 2026 results show a turnaround, with GMV up 12.9% and revenue rising 9.2%, and for the first time the company posted a modest adjusted net profit. Management’s guidance points to double‑digit GMV growth and full‑year profitability, which could underpin a substantial earnings upgrade. The analyst consensus projects an upside of roughly 88% versus the current price, implying significant upside potential if the profit trend holds. However, the company operates in China’s consumer‑cyclical internet‑retail sector, exposing it to heightened regulatory and geopolitical risk. Liquidity is a concern, as trading volume has been decreasing and market cap remains modest at about $403 million. In this context, the stock presents a blend of value appeal and emerging growth, with the near‑term risk balanced by a longer‑term upside narrative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Oversold RSI indicating potential bounce
  • Price below key moving averages reinforcing bearish bias
  • Decreasing volume suggesting limited short‑term buying pressure

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Q1 profit turnaround and double‑digit GMV growth
  • Attractive forward P/E and price‑to‑book ratios
  • Projected upside of ~88% from analyst targets

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained earnings improvement and profitability outlook
  • Low valuation multiples relative to peers
  • Exposure to regulatory and geopolitical risk mitigated by growth trajectory

Key Metrics & Analysis

Financial Health

Revenue Growth9.20%
Profit Margin-0.91%
P/E Ratio11.5
ROE-2.80%
ROA-1.57%
Debt/Equity13.95
P/B Ratio0.9

Technical Analysis

TrendBearish
RSI29.5
Support$2.47
Resistance$3.01
MA 20$2.80
MA 50$2.94
MA 200$3.13
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Target Price$4.75
Upside/Downside87.73%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.30
Volatility49.33%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.